NCT01394016 2024-09-19A Phase 1 Study of LY2835219 In Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed225 enrolled 31 charts
NCT04071262 2021-09-21A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed6 enrolled